Healios K.K. (OTCMKTS:HLOSF) Short Interest Down 6.4% in April

Healios K.K. (OTCMKTS:HLOSF) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 365,900 shares, a decline of 6.4% from the March 31st total of 391,100 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ? days.

Healios K.K. Stock Performance

OTCMKTS HLOSF opened at 0.99 on Wednesday. The company has a fifty day moving average of 0.95 and a two-hundred day moving average of 1.25. Healios K.K. has a 1 year low of 0.94 and a 1 year high of 1.31.

About Healios K.K.

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.